(Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytriaconta-4,8,12-trien-2-yl]nonadec-9-enamide

C61H111NO13 — CID 165236266

IUPAC(Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytriaconta-4,8,12-trien-2-yl]nonadec-9-enamide
SMILESCCCCCCCCC/C=C\CCCCCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CC/C=C/CCCCCCCCCCCCCCCCC
InChIInChI=1S/C61H111NO13/c1-3-5-7-9-11-13-15-17-19-21-22-23-24-25-26-27-28-29-30-32-34-36-38-40-42-44-50(65)49(62-53(66)45-43-41-39-37-35-33-31-20-18-16-14-12-10-8-6-4-2)48-72-60-58(71)56(69)59(52(47-64)74-60)75-61-57(70)55(68)54(67)51(46-63)73-61/h20,28-29,31,34,36,42,44,49-52,54-61,63-65,67-71H,3-19,21-27,30,32-33,35,37-41,43,45-48H2,1-2H3,(H,62,66)/b29-28+,31-20-,36-34+,44-42+
InChIKeyJNDKRRMPBIAPDS-DWQQTXGRSA-N
MW1066.55 g/mol
LogP10.39
Rot. Bonds48

About (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytriaconta-4,8,12-trien-2-yl]nonadec-9-enamide

(Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytriaconta-4,8,12-trien-2-yl]nonadec-9-enamide (PubChem CID 165236266) has the molecular formula C61H111NO13 and a molecular weight of 1066.55 g/mol. Its IUPAC name is (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytriaconta-4,8,12-trien-2-yl]nonadec-9-enamide.

Molecular Properties

Compound Name(Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytriaconta-4,8,12-trien-2-yl]nonadec-9-enamide
PubChem CID165236266
Molecular FormulaC61H111NO13
Molecular Weight1066.55 g/mol
Exact Mass1065.81
IUPAC Name(Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytriaconta-4,8,12-trien-2-yl]nonadec-9-enamide
SMILESCCCCCCCCC/C=C\CCCCCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CC/C=C/CCCCCCCCCCCCCCCCC
InChIInChI=1S/C61H111NO13/c1-3-5-7-9-11-13-15-17-19-21-22-23-24-25-26-27-28-29-30-32-34-36-38-40-42-44-50(65)49(62-53(66)45-43-41-39-37-35-33-31-20-18-16-14-12-10-8-6-4-2)48-72-60-58(71)56(69)59(52(47-64)74-60)75-61-57(70)55(68)54(67)51(46-63)73-61/h20,28-29,31,34,36,42,44,49-52,54-61,63-65,67-71H,3-19,21-27,30,32-33,35,37-41,43,45-48H2,1-2H3,(H,62,66)/b29-28+,31-20-,36-34+,44-42+
InChIKeyJNDKRRMPBIAPDS-DWQQTXGRSA-N
XLogP10.39
TPSA227.86 Ų
H-Bond Donors9
H-Bond Acceptors13
Rotatable Bonds48
Heavy Atoms75
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001066.55
LogP ≤ 510.39
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytriaconta-4,8,12-trien-2-yl]nonadec-9-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytriaconta-4,8,12-trien-2-yl]nonadec-9-enamide?
The IUPAC name of (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytriaconta-4,8,12-trien-2-yl]nonadec-9-enamide (CID 165236266) is (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytriaconta-4,8,12-trien-2-yl]nonadec-9-enamide.
What is the SMILES notation for (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytriaconta-4,8,12-trien-2-yl]nonadec-9-enamide?
The canonical SMILES for (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytriaconta-4,8,12-trien-2-yl]nonadec-9-enamide is CCCCCCCCC/C=C\CCCCCCCC(=O)NC(COC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O)C(O)/C=C/CC/C=C/CC/C=C/CCCCCCCCCCCCCCCCC.
What is the InChIKey of (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytriaconta-4,8,12-trien-2-yl]nonadec-9-enamide?
The InChIKey is JNDKRRMPBIAPDS-DWQQTXGRSA-N. The full InChI is InChI=1S/C61H111NO13/c1-3-5-7-9-11-13-15-17-19-21-22-23-24-25-26-27-28-29-30-32-34-36-38-40-42-44-50(65)49(62-53(66)45-43-41-39-37-35-33-31-20-18-16-14-12-10-8-6-4-2)48-72-60-58(71)56(69)59(52(47-64)74-60)75-61-57(70)55(68)54(67)51(46-63)73-61/h20,28-29,31,34,36,42,44,49-52,54-61,63-65,67-71H,3-19,21-27,30,32-33,35,37-41,43,45-48H2,1-2H3,(H,62,66)/b29-28+,31-20-,36-34+,44-42+.
What are the key properties of (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytriaconta-4,8,12-trien-2-yl]nonadec-9-enamide?
(Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytriaconta-4,8,12-trien-2-yl]nonadec-9-enamide has a molecular weight of 1066.55 g/mol, XLogP of 10.39, 48 rotatable bonds, 9 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytriaconta-4,8,12-trien-2-yl]nonadec-9-enamide is sourced from PubChem (CID 165236266), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).